New hope drug enters human testing for Tough-to-Treat cancers
Disease control
Recruiting now
This early-stage clinical trial is testing a new drug called VIB305 in people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find the safest and most effective dose and to see if the drug can help control the cancer. It will enro…
Phase: PHASE1, PHASE2 • Sponsor: Vibrant Sciences Limited • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC